Ticky's interview with Jackie, page-7

Thanks for the link AB.

I think management have learned the error of their ways. They should have had Vivagel on ANZ and European shelves much sooner, and dealt with the FDA as a separate issue. They lost serious time, revenue and feedback from users because of it.
Still, no one is perfect. I liked how JF constantly picked up the Fleurstat package. She should be immensly proud of the achievements so far.
JF did emphasise that vivagel would bring in revenue, and it was unspokenly clear that DEP is going to bring in far more revenue - eventually.
I am looking forward to a busy last two months of the financial year. And the quarterly cash report in the next few days.